Technical Note: Dosimetric impact of spherical applicator size in Intrabeam™ IORT for treating unicentric breast cancer lesions

Medical Physics
Yaseen Saleh, Hualin Zhang

Abstract

To characterize the dosimetric impact of using different sizes of spherical applicators in Intrabeam™ Intraoperative Radiation Therapy (IB-IORT) to treat unicentric cancer lesions after breast-conserving lumpectomy. Using the commissioned depth dose rates, the three-dimensional dosages of the 3.5, 4.0, 4.5, and 5.0 cm spherical applicators of the IB-IORT PRS400 machine were established. Five different cancer cell infiltration depths of unicentric breast lesions were formulated by a linearly declining cancer cell density distribution from the surgical surface. The equivalent uniform dose (EUD), which is the dosage of a homogeneous dose treatment for killing the same amount of cancer cells as IB-IORT in the same target volume, was then calculated using the modified linear quadratic model (MLQ). The radiobiological response of two types of cancer cell lines and three types of normal tissues in the TARGIT-A clinical trial of 20 Gy dose was estimated. The study was carried out for an acutely responding breast cancer cell line with an α/β ratio of 10 and a slow responding breast cancer cell line with an α/β ratio of 3.85, respectively. The cancer cell density at the surgical excision surface was assumed to be 0.01%, 0.1%, 1%, and 10%...Continue Reading

References

Aug 1, 1989·The British Journal of Radiology·J F Fowler
Jan 1, 1985·International Journal of Radiation Oncology, Biology, Physics·M V WilliamsJ F Fowler
Oct 1, 1996·Physics in Medicine and Biology·M A Ebert, P W Hoban
May 13, 1999·The New England Journal of Medicine·M J SilversteinW J Colburn
Mar 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Robert D ZwickerMohammed Mohiuddin
Nov 30, 2004·Physics in Medicine and Biology·M Guerrero, X Allen Li
Oct 31, 2007·International Journal of Radiation Oncology, Biology, Physics·Hualin ZhangWilliam Yuh
Aug 30, 2008·Seminars in Radiation Oncology·John P KirkpatrickLawrence B Marks
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clive DunneMalcolm R Kell
Feb 4, 2012·International Journal of Radiation Oncology, Biology, Physics·David J EatonMohammed R S Keshtgar
Dec 5, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Christian KirisitsFrank-André Siebert
Aug 21, 2014·Annals of Surgical Oncology·Melvin J SilversteinDavid Wazer
Sep 27, 2014·International Journal of Breast Cancer·Felix SedlmayerGerd Fastner
Dec 14, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Anne-Michelle NooneLynne Penberthy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.